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ABSTRACT 
A high pressure and high temperature continuous flow reactor has been used to intensify a Krapcho dealkoxy-
carbonylation reaction in the context of API synthesis. The reactor enables operation of the reaction above temperatures 
possible in batch and thus significantly increased conversion rates are achieved. Also a broader choice of solvents is 
possible by the use of the continuous process. Batch and continuous reaction are compared in terms of operation range 
and space-time-yield. Despite lower concentrations of the reactants in the continuous process, space-time-yield exceeds 
that of the batch process by more than an order of magnitude due to the higher reaction rates.    
Keywords: Flow synthesis, process intensification, Krapcho dealkoxycarbonylation 
INTRODUCTION 
The method of Krapcho is a simple procedure for the 
selective dealkoxycarbonylation of molecules under 
neutral conditions [1,2]. It involves heating of the 
respective reactant molecule in an aprotic polar solvent 
with added water and sometimes salts. At ambient 
pressure, the choice of solvent is limited to high boiling 
polar aprotic solvents such as DMF and DMSO due to 
the demanding temperatures. Figure 1 displays reaction 
temperature and time for several Krapcho reactions 
reported in literature [3,4]. 
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Figure 1: Overview over reaction conditions for different 
Krapcho reactions reported in literature, ntotal = 364 [3,4] 
Obviously, the majority of these reactions only 
progresses at temperatures well above 140 °C, still 
requiring reaction times of several hours. In order to 
intensify the reaction beyond the original batch protocol, 
a continuous high pressure and high temperature flow 
reactor is utilized to access reaction temperature 
windows not possible in batch. By pressurizing the 
reactor, also alternative low boiling solvents could be 
employed, benefiting from their high volatility for easier 
workup. The continuous reactor is tested for a typical 
Krapcho reaction with pharmaceutical relevance, 
namely the synthesis of 3,4-dihydro-1H-1-benzazepine-
2,5-dione (DHBD [5], Figure 2. DHBD and its 
derivatives are important precursor molecules for the 
synthesis of substituted paullones and paullone 
derivatives, a class of protein kinase inhibitors and anti-
cancer agents [6–8]. 
Figure 2: Krapcho dealkoxycarbonylation for the synthesis 
of DHBD in batch mode 
RESEARCH CONCEPT 
In order to examine the reaction in detail, a continuous 
high pressure and high temperature flow reactor has 
been designed and characterized [9]. 
As shown in Figure 3, the center piece of the setup is a 
stainless steel coil reactor with dimensions di x L = 1.016 
x 2,500 mm, VR = 2.027 mL, which is submerged in and 
heated by an oil bath. The reactor is fed by a HPLC 
pump and kept at a constant pressure of 37.5 bar to 
prevent boiling of the solvent. At a given flow rate, 
500 µL of the reactant solution are loaded in the sample 
loop and injected into the inlet stream.  
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Figure 3: Setup of the continuous flow reactor used to study 
the Krapcho reaction 
The reactor outlet stream is collected and analyzed via 
HPLC. In order to generate conversion-time-profiles 
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this procedure is repeated for various combinations of 
temperature (160 – 200 °C) and flow rate (0.1 – 2 mL 
min-1). For comparison batch reactions are performed in 
a Mettler Toledo EasyMax 102 synthesis workstation. 
Kinetic analysis 
The conversion-time-profile of the reactant XR can be 
described by a pseudo 1st order kinetic equation, where 
tR is the residence time of sample fluid element in the 
heated zone of the continuous reactor [10]: 
𝑋𝑅 = 1 − 𝑒𝑥𝑝(−𝑘 ∙ 𝑡𝑅)    (1) 
Since residence time distribution in the coil reactor is 
found to closely follow plug flow behavior [9], 
residence time tR is calculated via reactor volume VR and 
volumetric flow rate ?̇?, corrected by the expansion of
the fluid upon heating: 
𝑡𝑅 =
𝑉𝑅
?̇?
𝜌𝑆,𝑇
𝜌𝑆,25°𝐶
   (2) 
By fitting equation (1) to experimentally determined 
conversion-over-time data, rate constants k can be 
determined. By employing Arrhenius´ law, activation 
energy EA and frequency factor k0 may be calculated: 
𝑘(𝑇) = 𝑘0 ∙ 𝑒𝑥𝑝(−𝐸𝐴 (𝑅 · 𝑇)⁄ )    (3) 
Combination of equations (1) – (3) results in an 
expression for the conversion in the continuous reactor 
as function of temperature and flow rate [9]: 
𝑋𝑅(𝑇, ?̇?) = 1 − 𝑒𝑥𝑝 [−𝑘0 ∙ 𝑒
−
𝐸𝐴
𝑅𝑇 ∙
𝑉𝑅
?̇?
𝜌𝑆,𝑇
𝜌𝑆,25°𝐶
]   (4) 
RESULTS AND DISCUSSION 
Reaction characterization 
Since water is added as reactant, the influence of its 
concentration on reaction rate was examined.  
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Figure 4: Influence of the ratio of water and reactant on the 
rate of the dealkoxycarbonylation 
Figure 4 displays reaction rate constants for different 
ratios of added water to reactant concentration at varied 
reactant concentrations in solvents DMSO and THF. In 
general, rate constants increase with the amount of water 
added per reactant, until a maximum k-value is reached 
at a ratio of about 10. This behavior can be observed for 
different reactant concentrations ranging from 5 to 50 
mg mL-1 in DMSO.  
For no added water, the reaction still takes place. This 
might be due to the hygroscopic nature of DMSO, which 
always contains small amounts of water. For low ratios 
of added water to reactant concentration, error bars are 
significantly larger, indicating a lower accuracy of the 
used 1st order fit. In this regime, the reaction behaves 
more like a 2nd order reaction where water concentration 
becomes limiting. For THF as solvent, a similar 
behavior is observed, however, the maximum value of k 
is significantly lower than that observed in DMSO.  
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Figure 5: Conversion profiles at different temperatures in 
DMSO in batch and continuous mode [9]  
Figure 5 displays typical conversion-time profiles of R 
to DHBD in DMSO for different temperatures in the 
batch and continuous reactor. Conversion profiles were 
also modeled using equation (4) and batch data to fit the 
parameters. Dotted curves represent extrapolations of 
that model to higher temperatures, with parameters 
extracted from reactions ≤ 160 °C.  
Batch and continuous conversions are in very good 
agreement, however, the reaction temperature in batch 
is limited. Employing the continuous reactor, tempera-
tures of up to 200 °C can be realized resulting in a 
significantly intensified reaction. Consequently, shorter 
reaction times are sufficient to reach complete 
conversion (~ 3 min vs. ~ 3 h respectively).  
Solvent selection 
To identify an optimal solvent for the Krapcho reaction, 
different solvents have been examined as reaction 
medium. Figure 6 summarizes the derived rate constants 
at different temperatures. Whilst aprotic-polar solvents 
show significant reaction rates, ethanol and i-propanol 
are not suited as reaction medium. Here, the equilibrium 
between the reactant and a carboxylate intermediate 
might be affected negatively. Considering aprotic-polar 
solvents, rate constants do not differ dramatically. 
However, DMSO and acetone show the highest rate 
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constants while values of propylene carbonate (PC) and 
ethyl acetate (EA) are about 25 % lower.  
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Figure 6: Reaction rate constants k in different solvents 
Besides reaction rate, reactant solubility in the 
respective solvent is an important property. Solubility 
curves of R in different solvents, measured via HPLC 
from a saturated solution, for n ≥ 3 samples each, are 
given in Figure 7. Only DMSO, DMF and DMAc 
exhibit high solubility for the reactant R while acetone, 
PC, EA and ACN show unsatisfactory solubility 
especially at room temperature. Taking a combined look 
at reaction rate and solubility, it becomes apparent that 
DMSO, DMAc and DMF are the most promising 
solvent candidates, since they show both, relatively high 
rate constants and good solubility. THF is the best of the 
low boiling solvents. While the solubility for the 
reactant is not as high as in DMSO for example, it still 
exceeds the other low boiling solvents by a factor ~ 3.   
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Figure 7: Solubility curves of the reactant R in different 
aprotic-polar solvents, n ≥ 3 
Comparison of batch and continuous process 
To assess the process modes, it is interesting to consider 
the operation range of the respective process and 
compare the space-time-yield (STY) as a measure of 
process performance. 
Operation ranges, given in Figure 8, can be interpreted 
as follows: In the batch process, solubility is not an issue 
since dissolution of the reactant can take place during 
heating of the mixture and at reaction temperature, 
solubility is high anyway. In contrast, in continuous 
mode, the reactant has to be dissolved prior to pumping 
to prevent reactor clogging and pump damage by un-
dissolved solids, so reactant concentration is limited. In 
the batch process reaction temperature is limited by the 
boiling temperature of the reaction mixture. Since water 
is added proportional to the reactant concentration, 
maximum possible reaction temperature is decreasing 
with increasing reactant concentration (see Figure 8). In 
the pressurized continuous reactor, this is not an issue 
and higher reaction temperatures can be reached. 
0 20 40 60 80 100 120 140 160 180 200
120
140
160
180
200
THF
R
ea
ct
io
n 
te
m
pe
ra
tu
re
  /
  °
C
Reactant concentration  /  mg mL-1
 DMSO - batch
 DMAc - batch
 DMF - batch
 DMSO - conti
 DMAc - conti
 DMF - conti
 THF - conti
DMAcDMSODMF
continuous:
DMF
DMSO
DMAc
batch:
Figure 8: Operation range of the batch and the continuous 
process 
To quantitatively the influence of reaction temperature 
and concentration on the performance of both processes, 
STY is theoretically assessed as follows: For the batch, 
STY depends on the chosen reactant concentration cR and 
the resulting processing time tproc which is a function of 
the reaction temperature und ultimately of the reactant 
concentration due to added water as stated above: 
𝑆𝑇𝑌𝑏 =
𝑐𝑅
𝑡𝑝𝑟𝑜𝑐.(𝑐𝑅)
∙ 𝑀𝐷𝐻𝐵𝐷 𝑀𝑅⁄    (5) 
For the continuous process, STY follows from the 
maximum solubility of the reactant SR and the 
volumetric flow rate necessary to provide a sufficient 
reaction time for a conversion of 99.9 %: 
𝑆𝑇𝑌𝑐 = 𝑆𝑅(𝑇𝑆) ∙
?̇?𝑋=99.9% (𝑇𝑅)
𝑉𝑅
∙ 𝑀𝐷𝐻𝐵𝐷 𝑀𝑅⁄    (6) 
The calculated STY are displayed in Figure 9, where 
values for batch represent the highest STY possible at the 
optimum reactant concentration and temperature while 
the values for the continuous process are calculated for 
dissolution temperature TS = 25 °C and reaction 
temperature TR = 200 °C. 
It can be concluded that the STY possible in the batch 
process is about an order of magnitude smaller than in 
the continuous process for the high boiling solvents. 
This can be contributed to the low temperatures and 
therefore slow reaction in batch. This effect can be seen 
especially for THF where the low boiling point would 
lead to reaction times of several years. Although reactant 
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concentration is higher in the batch process, this 
advantage does not balance out the slow rates. In 
continuous mode, due to the fast reaction, DMF, DMSO 
and DMAc show the highest STY of around 10 – 20 
mg mL-1reactor min-1.  
Figure 9: Calculated STY for the batch and continuous 
process in logarithmic scaling 
In conclusion, the superior performance of the 
continuous process can mainly be attributed to the 
possibility to operate at high temperatures. Although 
similar temperatures could also be reached in a sealed or 
pressurized batch reactor, the distinct advantage of a 
high surface to volume ratio and therefore excellent heat 
transfer properties of the continuous reactor would still 
lead to an advantage over a pressurized batch reactor. 
The batch reactor would need longer heating and cooling 
times and therefore an overall longer processing time 
rendering the fast reaction times useless. In addition, 
higher safety properties usually attributed to continuous 
systems and low cost for the commonly available 
materials are distinct advantages of the continuous 
process. 
CONCLUSIONS 
In this contribution, a continuous process for the 
intensification of the Krapcho dealkoxycarbonylation 
reaction is established and the synthesis of the pharma-
ceutically relevant molecule DHBD is studied as model 
process in detail. To assess the performance of the 
continuous reactor it is compared to the original batch 
process.  
It was found that the dealkoxycarbonylation can be 
significantly intensified in the continuous reactor due to 
the high reaction temperatures possible, resulting in a 
reaction time reduction from 3 h in batch to < 3 min in 
the continuous reactor. Exploiting the pressurized 
reaction conditions in the continuous reactor, the choice 
of solvent can be broadened significantly. It was found, 
that all aprotic-polar solvents under investigation are 
principally suited as reaction medium since similar rates 
were measured. However, due to the higher solubility 
DMSO, DMF and DMAc are preferred. 
Compared to the batch process, STY in the continuous 
reactor is one to two orders of magnitude higher when 
operated under higher temperatures that cannot be 
realized in the batch reactor due to boiling of the reactant 
mixture. 
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NOMENCLATURE 
cR [mmol mL-1] reactant concentration 
di [mm] inner diameter
EA [J mol-1]  activation energy  
k [s-1] reaction rate constant  
k0 [s-1] frequency factor  
L [m] length of the coil-reactor 
M [g mol-1] molar mass 
R [J K-1 mol-1] universal gas constant 
ρS [g mL-1]  solvent density  
S [mg mL-1] solubility 
STY [mg mL-1 min-1] space time yield 
T [°C], [K] temperature 
VR [mL] reactor volume  
V̇ [mL min-1] volumetric flow rate 
XR [-] reactant conversion 
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